← Back to Search

Behavioral Intervention

Community-based obesity treatment (PP) for Obesity

N/A
Waitlist Available
Led By Sharon J Herring, MD MPH
Research Sponsored by Temple University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months
Awards & highlights

Summary

The purpose of this study is to determine the effect of the community-based obesity treatment (PP), compared to usual care (UC), on changes in maternal weight over 12 months.

Eligible Conditions
  • Obesity

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Weight loss (kilograms)
Secondary study objectives
Health-related quality of life
Hemoglobin A1c (HbA1c)
Insulin Resistance
+4 more
Other study objectives
Utilize Reach Effectiveness Adoption Implementation (RE-AIM) to evaluate the intervention's dissemination potential

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Community-based obesity treatment (PP)Experimental Treatment1 Intervention
The PP arm includes expanded obesogenic behavior change goals, tailored skills training materials, interactive self-monitoring text messages, video testimonials, and interpersonal counseling support through health coach calls and Facebook.
Group II: Usual care (UC)Active Control1 Intervention
Usual postpartum WIC care
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Community-based obesity treatment (PP)
2016
N/A
~300

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,889 Previous Clinical Trials
47,833,907 Total Patients Enrolled
254 Trials studying Obesity
211,261 Patients Enrolled for Obesity
Temple UniversityLead Sponsor
313 Previous Clinical Trials
87,997 Total Patients Enrolled
25 Trials studying Obesity
9,114 Patients Enrolled for Obesity
Sharon J Herring, MD MPHPrincipal InvestigatorTemple University
~33 spots leftby Sep 2025